Nathalie GarÃ§on is Vice President and Head of Global Adjuvant Centre for Vaccine Development at GSK Biologicals. Following the successful completion of two PhDs, one in biological pharmacy and the other in immunotoxicology and immunopharmacology, Dr GarÃ§on moved to the UK for 1 year as a postdoctoral research fellow at the Royal Free Hospital in London, undertaking research on liposomes in vaccines. She provides leadership within GSK Biologicals in the field of adjuvants, from discovery to registration and commercialisation of adjuvanted vaccines. Dr GarÃ§onâ€™s expertise in vaccinology extends from research to manufacturing, in particular immunology, adjuvant and formulation technologies, analytical methods, animal experimentation and toxicology/safety evaluation and testing. She has authored over 40 papers and book chapters, and holds more than 200 patents. Dr GarÃ§on is the 2014 S. Plotkin award for life time contribution in vaccines and vaccine technologies.